Staff Directory

Filter By Surname
Filter By Position
Filter By Keyword
Filter By Cancer Type
Search
Professor Kairbaan Hodivala-Dilke
Deputy Institute Director, Professor of the Tumour Microenvironment

Cancers are composed of both tumour and stromal compartments. We are interested in understanding the molecular basis of how the tumour stroma contributes to tumour growth, therapy resistance and spread, in various solid tumours including lung cancers, pancreatic cancer and melanoma.

Dr Paolo Gallipoli
Clinical Senior Lecturer in Haemato-Oncology

My research interests focus on mechanisms of disease initiation and maintenance and the identification and validation of novel therapeutic targets in myeloid leukaemias.

Professor Richard Grose
Professor of Cancer Cell Biology

We are interested in how cancer cells interact with each other and the microenvironment. We investigate how cancer cells develop resistance to therapies and design drug combination approaches to overcome this.

Dr Ioanna Keklikoglou
Lecturer

Our group focuses on understanding the molecular and cellular mechanisms that mediate resistance to anti-cancer therapies in breast cancer. We are interested in dissecting the microenvironmental cues that orchestrate specific tumour responses and metastasis formation.

Dr Michelle Lockley
Reader in Medical Oncology, Honorary Consultant

Our lab aims to improve treatments for women with ovarian cancer, particularly those that are resistant to chemotherapy. We are interested in developing therapies that can adapt to the evolution of chemotherapy resistance over time.

Dr Eve Coulter

My research focuses on novel strategies to enrich, isolate and characterise a chemo-resistant population in patients with follicular lymphoma.

Dr Vilma Dembitz

My research is focused on the role of lipid metabolism in resistance to therapy in acute myeloid leukemia.

Dr Ana Levi

My focus is on investigating the epigenetic regulation of the PI3K pathway and identifying an effective combination therapy that will disable compensatory bypass routes, overcoming drug resistance.

Emma Newport

I am working to produce a bank of pancreatic cancer organoids from KPC mice. We hope to use these to model PDAC in vivo and in vitro.

Dr Celine Philippe

My project focuses on the translation reprogramming in acute myeloid leukaemia upon stresses such as chemotherapy.

Dr Laura Wisniewski

My project looks at the modelling of cancer for improved therapy development. I am carrying out in vivo cancer experiments, with and without modifications of the tumour microenvironment, to examine effects of such treatments on anti-cancer therapy efficacy.